Splice variants as novel targets in pancreatic ductal adenocarcinoma
Abstract Despite a wealth of genomic information, a comprehensive alternative splicing (AS) analysis of pancreatic ductal adenocarcinoma (PDAC) has not been performed yet. In the present study, we assessed whole exome-based transcriptome and AS profiles of 43 pancreas tissues using Affymetrix exon a...
Guardado en:
Autores principales: | Jun Wang, Laurent Dumartin, Andrea Mafficini, Pinar Ulug, Ajanthah Sangaralingam, Namaa Audi Alamiry, Tomasz P. Radon, Roberto Salvia, Rita T. Lawlor, Nicholas R. Lemoine, Aldo Scarpa, Claude Chelala, Tatjana Crnogorac-Jurcevic |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5e296d11dc7c438894ef3382cb3a4a71 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma
por: Michelle R. Goulart, et al.
Publicado: (2021) -
Gα15 in early onset of pancreatic ductal adenocarcinoma
por: Giulio Innamorati, et al.
Publicado: (2021) -
Advances in Pancreatic Ductal Adenocarcinoma Treatment
por: Eric M. Anderson, et al.
Publicado: (2021) -
Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinoma.
por: Luigi Laghi, et al.
Publicado: (2012) -
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
por: Alexander G. Raufi, et al.
Publicado: (2021)